EU Legislation on Manufacture and Importation
DIRECTIVE 2001/83/EC, TITLE IV, MANUFACTURE AND IMPORTATION
Title IV: Manufacture and Importation
Editor’s note
Title IV of this directive is reproduced below. Reference should be made to the full Directive for the preamble, definitions and the general and final provisions.
Article 46a
1 For the purposes of this Directive, manufacture of active substances used as starting materials shall include both total and partial manufacture or import of an active substance used as a starting material as defined in Part I, point 3.2.1.1 (b) Annex I, and the various processes of dividing up, packaging or presentation prior to its incorporation into a medicinal product, including repackaging or relabelling, such as are carried out by a distributor of starting materials.
2 The Commission shall be empowered to adapt paragraph 1 to take account of scientific and technical progress. That measure, designed to amend non-essential elements of this Directive, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 121(2a).
Article 46b
1 Member States shall take appropriate measures to ensure that the manufacture, import and distribution on their territory of active substances, including active substances that are intended for export, comply with good manufacturing practice and good distribution practices for active substances.
2 Active substances shall only be imported if the following conditions are fulfilled:
(a) the active substances have been manufactured in accordance with standards of good manufacturing practice at least equivalent to those laid down by the Union pursuant to the third paragraph of Article 47; and
(b) the active substances are accompanied by a written confirmation from the competent authority of the exporting third country of the following:
(i) the standards of good manufacturing practice applicable to the plant manufacturing the exported active substance are at least equivalent to those laid down by the Union pursuant to the third paragraph of Article 47;
(ii) the manufacturing plant concerned is subject to regular, strict and transparent controls and to the effective enforcement of good manufacturing practice, including repeated and unannounced inspections, so as to ensure a protection of public health at least equivalent to that in the Union; and